AQST - Aquestive Therapeutics GAAP EPS of -$0.10 beats by $0.01 revenue of $13.24M beats by $2.23M August, 07 2023 04:05 PM Aquestive Therapeutics Inc. 2023-08-07 16:05:33 ET Aquestive Therapeutics press release ( NASDAQ: AQST ): Q2 GAAP EPS of -$0.10 beats by $0.01 . Revenue of $13.24M (-0.2% Y/Y) beats by $2.23M . For further details see: Aquestive Therapeutics GAAP EPS of -$0.10 beats by $0.01, revenue of $13.24M beats by $2.23M